Transforming growth factor β3 for the prevention of vocal fold scarring
Authors:
- 17 January 2012
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 122 (3) , 583-589
Abstract
Objectives/Hypothesis: Vocal fold scarring poses a therapeutic challenge. It causes hoarseness and decreases the quality of life. Transforming growth factor β3 (TGFβ3) is highly expressed in fetal wounds that heal without scarring, and administration of TGFβ3 has been reported to prevent scarring of the skin and the buccal mucosa. Thus TGFβ3 is considered to be a key molecule in scar‐free healing. This study aimed to examine the ability of TGFβ3 to prevent vocal fold scarring, with particular attention paid to the distribution of extracellular matrices and functional outcomes.Study Design: Prospective study using an animal model.Methods: Ten beagles were used in this study; 500 μL of TGFβ3 (0.5 μg/mL: 5 beagles) or saline (5 beagles) was injected into the vocal fold lamina propria. Fifteen minutes after injection, vocal folds were injured by stripping off the entire layer of the lamina propria. Six months after surgery, animals were euthanized and the larynges were harvested. Vibratory and histologic examinations were performed.Results: The administration of TGFβ3 suppressed granulation‐tissue formation and scarring. TGFβ3‐treated vocal folds showed significantly better vibratory properties, resembling normal vocal folds. Histologic analysis revealed favorable restoration of elastin and hyaluronic acid in the lamina propria. The distribution of collagen was well organized, and collagen deposition was less dense in TGFβ3‐treated vocal folds compared to sham‐treated vocal folds.Conclusions: Administration of TGFβ3 before injury significantly suppressed scar formation and induced favorable restoration of extracellular matrices in the vocal fold lamina propria, resulting in much improved phonatory function.Keywords
This publication has 27 references indexed in Scilit:
- Prevention of buccal mucosa scarring with transforming growth factor β3The Laryngoscope, 2011
- Treatment of acute vocal fold scar with local injection of basic fibroblast growth factor: a canine studyActa Oto-Laryngologica, 2010
- Chronic vocal fold scar restoration with hepatocyte growth factor hydrogelThe Laryngoscope, 2009
- A “traffic control” role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healingJournal of Cell Biology, 2006
- Three Key Residues Underlie the Differential Affinity of the TGFβ Isoforms for the TGFβ Type II ReceptorJournal of Molecular Biology, 2006
- Scar–free healing: from embryonic mechanisms to adult therapeutic interventionPhilosophical Transactions of the Royal Society B: Biological Sciences, 2004
- Characterization of Vocal Fold Scarring in a Canine ModelThe Laryngoscope, 2003
- TGF-β3 Stimulates and Regulates Collagen Synthesis Through TGF-β1-Dependent and Independent MechanismsJournal of Investigative Dermatology, 1997
- Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healingJournal of Cellular Physiology, 1991
- TGF‐β Receptors and TGF‐β Binding Proteoglycans: Recent Progress in Identifying Their Functional PropertiesAnnals of the New York Academy of Sciences, 1990